Context Therapeutics Inc. Income Statement

Income Statement Dec2020 Dec2021
Revenue & cost
Revenue -0.66M-0.06M
Operating items
Research & Development 1.64M3.81M
Selling, General & Administrative 0.93M3.63M
Operating Expenses 2.57M7.44M
Operating Income -2.57M-10.53M
EBIT -2.57M-10.53M
Non-operating items
Other Non Operating Income 9.88M0.01M
Non Operating Income 0.12M
Net income details
EBT -3.23M-10.59M
Profit After Tax 6.64M-10.46M
Income from Continuing Operations -3.23M-10.59M
Consolidated Net Income -3.23M-10.59M
Income towards Parent Company -3.23M-10.59M
Net Income towards Common Stockholders -3.23M-10.59M
Additional items
EPS (Basic) 3.07-3.69
EPS (Weighted Average and Diluted) -3.96-3.69
Shares Outstanding (Weighted Average) 10.21M15.97M
EBITDA -2.57M-10.53M
Interest Expenses 0.66M0.06M